[go: up one dir, main page]

NO996442L - Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet - Google Patents

Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet

Info

Publication number
NO996442L
NO996442L NO996442A NO996442A NO996442L NO 996442 L NO996442 L NO 996442L NO 996442 A NO996442 A NO 996442A NO 996442 A NO996442 A NO 996442A NO 996442 L NO996442 L NO 996442L
Authority
NO
Norway
Prior art keywords
treatment
sleep apnea
receptors
manufacture
apnea syndrome
Prior art date
Application number
NO996442A
Other languages
English (en)
Other versions
NO996442D0 (no
NO325520B1 (no
Inventor
Francoise Cattelin
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO996442D0 publication Critical patent/NO996442D0/no
Publication of NO996442L publication Critical patent/NO996442L/no
Publication of NO325520B1 publication Critical patent/NO325520B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19996442A 1997-06-26 1999-12-23 Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av sovnapnesyndromet NO325520B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707998A FR2765107B1 (fr) 1997-06-26 1997-06-26 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
PCT/FR1998/001100 WO1999000119A1 (fr) 1997-06-26 1998-06-02 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil

Publications (3)

Publication Number Publication Date
NO996442D0 NO996442D0 (no) 1999-12-23
NO996442L true NO996442L (no) 2000-02-28
NO325520B1 NO325520B1 (no) 2008-06-02

Family

ID=9508467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996442A NO325520B1 (no) 1997-06-26 1999-12-23 Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av sovnapnesyndromet

Country Status (28)

Country Link
US (1) US6143792A (no)
EP (1) EP1014960B1 (no)
JP (1) JP3503953B2 (no)
KR (1) KR20010014186A (no)
CN (1) CN1154485C (no)
AT (1) ATE232094T1 (no)
AU (1) AU728227B2 (no)
BG (1) BG104038A (no)
BR (1) BR9810337A (no)
CA (1) CA2295119C (no)
CZ (1) CZ291935B6 (no)
DE (1) DE69811248T2 (no)
EE (1) EE9900595A (no)
ES (1) ES2191942T3 (no)
FR (1) FR2765107B1 (no)
HU (1) HU229058B1 (no)
ID (1) ID23799A (no)
IL (1) IL133632A (no)
IS (1) IS2356B (no)
NO (1) NO325520B1 (no)
NZ (1) NZ502495A (no)
PL (1) PL190723B1 (no)
RU (1) RU2218917C2 (no)
SK (1) SK283845B6 (no)
TR (1) TR199903197T2 (no)
TW (1) TW580386B (no)
UA (1) UA59397C2 (no)
WO (1) WO1999000119A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
PT1066036E (pt) * 1998-02-27 2006-09-29 Univ Illinois Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
FR2787328A1 (fr) 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
CA2371822A1 (en) * 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
WO2004009586A1 (en) * 2002-07-19 2004-01-29 Biovitrum Ab Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
AU2005319367B2 (en) 2004-12-20 2012-05-24 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
EP2186511A1 (en) * 2008-11-13 2010-05-19 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
US20120108669A1 (en) * 2008-11-13 2012-05-03 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
EP2266554A1 (en) * 2009-05-26 2010-12-29 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2255726A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
EP0449561A3 (en) * 1990-03-29 1992-04-01 Eli Lilly And Company Use of (r)-norfluoxetine in the preparation of a medicament with affinity to 5ht1c receptors
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
IL103106A (en) * 1991-09-25 1998-06-15 Sanofi Elf Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them
RU2043125C1 (ru) * 1992-05-15 1995-09-10 Эдуард Арутюнович Петросян Способ профилактики осложнений неингаляционного наркоза

Also Published As

Publication number Publication date
BR9810337A (pt) 2000-09-05
ES2191942T3 (es) 2003-09-16
NZ502495A (en) 2000-10-27
CA2295119A1 (en) 1999-01-07
CA2295119C (en) 2007-02-13
TW580386B (en) 2004-03-21
JP3503953B2 (ja) 2004-03-08
HU229058B1 (en) 2013-07-29
UA59397C2 (uk) 2003-09-15
DE69811248T2 (de) 2003-12-04
TR199903197T2 (xx) 2000-05-22
SK184599A3 (en) 2000-06-12
CN1154485C (zh) 2004-06-23
CZ291935B6 (cs) 2003-06-18
WO1999000119A1 (fr) 1999-01-07
PL337871A1 (en) 2000-09-11
ATE232094T1 (de) 2003-02-15
EE9900595A (et) 2000-08-15
RU2218917C2 (ru) 2003-12-20
PL190723B1 (pl) 2005-12-30
NO996442D0 (no) 1999-12-23
HK1028351A1 (en) 2001-02-16
IS5316A (is) 1999-12-21
IL133632A0 (en) 2001-04-30
HUP0002170A3 (en) 2001-12-28
SK283845B6 (sk) 2004-03-02
AU728227B2 (en) 2001-01-04
NO325520B1 (no) 2008-06-02
AU8024398A (en) 1999-01-19
KR20010014186A (ko) 2001-02-26
CZ469599A3 (cs) 2000-04-12
JP2001520678A (ja) 2001-10-30
IL133632A (en) 2003-10-31
FR2765107A1 (fr) 1998-12-31
BG104038A (en) 2001-04-30
EP1014960B1 (fr) 2003-02-05
DE69811248D1 (de) 2003-03-13
ID23799A (id) 2000-05-11
US6143792A (en) 2000-11-07
HUP0002170A2 (hu) 2001-11-28
EP1014960A1 (fr) 2000-07-05
FR2765107B1 (fr) 2000-03-24
IS2356B (is) 2008-04-15
CN1265586A (zh) 2000-09-06

Similar Documents

Publication Publication Date Title
NO996442L (no) Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
KR960700059A (ko) 파킨슨씨 병 및 파킨슨 중후군의 치료에 카르바마제핀 및 옥스카르바제핀의 이용(application of carbamazepine and oxcarbazepine in the treatment of parkinson&#39;s disease and parkinsonian syndromes)
DE60234616D1 (de) Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
ID26128A (id) Senyawa-senyawa aminotetralin tersubstitusi-n sebagai ligan-ligan untuk reseptor neupeptida y y5 yang bermanfaat dalam pengobatan obesitas dan gangguan-gangguan lain
IL179017A0 (en) Solid oral dosage form comprising valsartan
NO20020574L (no) Substituerte 1,5-dihydropyrrol-2-on derivater som er virksomme som NMDA-reseptorantagonister for behandlingen avsmertetilstanden
SE9702651D0 (sv) Novel compounds
IL206566A0 (en) Use of an antagonist to the igs4 neuromedin receptor polypeptide for the preparation of a medicament for the treatment of a disease related to the expression or acitivity of the igs4 neuromedin receptor polypeptide
ES2156444T3 (es) Nuevos compuestos.
HUP0203338A2 (hu) Integrin receptor ligandumok
IS2702B (is) Notkun á (11beta, 17beta)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón í meðhöndluninni á alvarlegri geðdeyfðartruflun
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
MXPA01006319A (es) Uso de los antagonistas del receptor para 5ht, para el tratamiento de sindrome de fatiga cronica.
IL143143A0 (en) USE OF A 5HT2A AND 5HT2A/C RECEPTOR ANTAGONIST FOR PREPARING MEDICINES FOR TREATING SNORING AND HIGH RESISTAnCE SYNDROME OF UPPER ANATOMICAL AIRWAYS
BR0314945A (pt) Uso de antagonistas de receptor 5-ht2 para tratamento de distúrbios de sono
WO2004002399A3 (en) Use of gaba-c receptor antagonists for the treatment of myopia
ZA9427B (en) Use of riluzole for promoting restoration following radiation
ATE218366T1 (de) Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees